chr4-106327500-TA-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001142416.2(AIMP1):c.162delA(p.Lys54AsnfsTer2) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000459 in 1,613,064 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001142416.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251190Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135810
GnomAD4 exome AF: 0.0000438 AC: 64AN: 1460852Hom.: 0 Cov.: 30 AF XY: 0.0000482 AC XY: 35AN XY: 726776
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74366
ClinVar
Submissions by phenotype
Hypomyelinating leukodystrophy 3 Pathogenic:3
Variant summary: AIMP1 c.162delA (p.Lys54AsnfsX2) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant allele was found at a frequency of 3.2e-05 in 251190 control chromosomes (gnomAD). c.162delA has been reported in the literature in a homozygous individual affected with pontocerebellar hypoplasia.The following publication has been ascertained in the context of this evaluation (PMID: 30924036). ClinVar contains an entry for this variant (Variation ID: 590774). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
not provided Pathogenic:2
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31980526, 30924036) -
This sequence change creates a premature translational stop signal (p.Lys54Asnfs*2) in the AIMP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AIMP1 are known to be pathogenic (PMID: 21092922). This variant is present in population databases (rs750731609, gnomAD 0.009%). This premature translational stop signal has been observed in individual(s) with hypomyelinating leukodystrophy (PMID: 30924036). ClinVar contains an entry for this variant (Variation ID: 590774). For these reasons, this variant has been classified as Pathogenic. -
AIMP1-related disorder Pathogenic:1
The AIMP1 c.162delA variant is predicted to result in a frameshift and premature protein termination (p.Lys54Asnfs*2). This variant was reported in the homozygous state in an individual with pontocerebellar hypoplasia (Accogli et al. 2019. PubMed ID: 30924036). This variant is reported in 0.0085% of alleles in individuals of Latino descent in gnomAD. Frameshift variants in AIMP1 are expected to be pathogenic. This variant is interpreted as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at